Hendra virus (HeV) causes a zoonotic disease with high mortality that is transmitted to humans from bats of the genus Pteropus (flying foxes) via an intermediary equine host. Factors promoting spillover from bats to horses are uncertain at this time, but plausibly encompass host and/or agent and/or environmental factors. There is a lack of HeV sequence information derived from the natural bat host, as previously sequences have only been obtained from horses or humans following spillover events. In order to obtain an insight into possible variants of HeV circulating in flying foxes, collection of urine was undertaken in multiple flying fox roosts in Queensland, Australia. HeV was found to be geographically widespread in flying foxes with a number of HeV variants circulating at the one time at multiple locations, while at times the same variant was found circulating at disparate locations. Sequence diversity within variants allowed differentiation on the basis of nucleotide changes, and hypervariable regions in the genome were identified that could be used to differentiate circulating variants. Further, during the study, HeV was isolated from the urine of flying foxes on four occasions from three different locations. The data indicates that spillover events do not correlate with particular HeV isolates, suggesting that host and/or environmental factors are the primary determinants of bat-horse spillover. Thus future spillover events are likely to occur, and there is an on-going need for effective risk management strategies for both human and animal health.
Citation: Smith I, Broos A, de Jong C, Zeddeman A, Smith C, Smith G, et al. (2011) Identifying Hendra Virus Diversity in Pteropid Bats. PLoS ONE 6(9): e25275. doi:10.1371/journal.pone.0025275
Editor: Leo L. M. Poon, University of Hong Kong, Hong Kong
Received: July 1, 2011; Accepted: August 30, 2011; Published: September 28, 2011
Copyright: © 2011 Smith et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by funding from the Wildlife and Exotic Disease Preparedness Program and Australian Biosecurity Collaborative Research Centre for Emerging Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Hendra virus (HeV) belongs to the genus Henipavirus (family Paramyxoviridae, subfamily Paramyxovirinae), and is an emerging zoonotic virus , . The virus is transmitted to humans via an intermediary equine host from bats of the genus Pteropus (Order Chiroptera, suborder, Megachiroptera, Family Pteropodidae) , , . These bats are colloquially referred to as flying foxes.
The HeV virion is pleomorphic, measuring between 38 and 600 nm with a double-fringed envelope as viewed by negative contrast staining under the electron microscope . The genome of HeV consists of a nonsegmented, single stranded, negative sense RNA of 18234 nucleotides that conforms to the “rule of six” for paramyxoviruses . The genomic RNA forms a ribonucleoprotein core with the three viral proteins, the nucleoprotein (N), the phosphoprotein (P) and the large (L) protein which function in replication and transcription of the genome. The genomic order is 3′- N, P, matrix (M), fusion (F), glycoprotein (G), L-5′. The P gene also codes multiple non-structural proteins, the C, V, W and a putative SB protein .
HeV was first identified in 1994 following an outbreak in Hendra, a suburb of Brisbane, Queensland, Australia that resulted in the infection of 20 horses and two humans , . There have been 31 identified spillovers of Hendra virus, resulting in a total 66 attributed equine cases and 7 human cases resulting in 4 human deaths (Table 1) –. In an unprecedented year for HeV activity, 17 spillovers resulting in 21 infections in horses have been identified between June and August 2011. The first infection in a dog was also diagnosed. Due to its wide host range, high mortality and lack of effective prevention or treatment modalities, HeV is classified in the highest biological safety category 4 (BSL4).
Transmission from horses to humans has occurred following close contact with horses through performance of necropsies, during husbandry and veterinary procedures, and is thought to occur via respiratory droplets, cuts and abrasions, and mucous membranes. The mode of transmission from bats to horses has not been fully elucidated, but is thought to occur following ingestion of contaminated food or contact with contaminated surfaces –.
To date, the increase in our knowledge of Hendra virus diversity has been incremental via sequence elaboration from sporadic equine spillover events that have effectively acted as sentinel surveillance (Table 1). This study sought to identify virus diversity in flying fox populations, and was an outcome of the three-year HeV surveillance study of free-living flying fox populations reported by Field et al. (2011) . Our aim was to identify any correlation between particular variants and spillover to horses, and in turn provide more information for the development of risk management strategies and response preparedness. Equally importantly, the identification of variants circulating in the natural host ensure diagnostic assays remain current and sensitive to all HeV variants that might infect horses, ensuring that the likelihood of missed or delayed diagnosis is minimised.
Materials and Methods
This study was approved by the Queensland Department of Employment, Economic Development and Innovation and the animal ethics permit number was SA 2008/10/270 and the approval for collection from native animals was approved by the Queensland Department of Environment and Natural Resources under permit number WISP05810609.
Details of the sample collection, handling and screening by PCR are presented in Field et al. 2011 . In summary, colonies of flying foxes at roost were sampled by placing plastic sheeting under roosting sites shortly before flying foxes return to roost. Pooled urine samples were collected from the sheets approx one hour after returned to roost , . Samples were held on wet ice in the field, transferred to the Biosecurity Sciences Laboratory (BSL) on wet ice (SEQ) or dry ice (FNQ), and stored at −70°C at the BSL. Prior to March 2009, samples were transferred to the Queensland Health Forensics and Scientific Services (QHFSS) laboratory for RNA extraction and screening by quantitative-PCR (qPCR); subsequently extraction and screening was done at BSL.
Isolation of Hendra virus
Isolation from pooled urine samples was attempted at the CSIRO Australian Animal Health Laboratory at biological safety level 4 in Vero cells (ATCC CCL81), and primary Pteropus alecto cell cultures (kidney, foetal, lung)  grown in Dulbecco's Modified Eagle's Medium nutrient mixture F-12 HAM (Sigma) supplemented with foetal calf serum.
Conventional PCR and sequencing
Amplification of viral RNA directly from urine was achieved by nested RT-PCR using high fidelity enzymes (Superscript III Platinum Taq (Invitrogen)) and virus specific primers. Areas initially targeted for sequencing were based on the positions of TaqMan assays that were in use in Australia.
First round cycling was performed on RNA to amplify a 2–3 kb product as follows: reverse transcription at 48°C for 30 mins then, initial denaturation at 94°C for 4 min, followed by 35 cycles of 94°C for 30 sec, 50°C for 30 sec, 68°C for 3 min then one cycle of 68°C for 7 min. Second round cycling was performed as above without the reverse transcription step using primer sets to amplify overlapping fragments. PCR products were electrophoresed on a 1% agarose gel and purified using the Qiagen gel extraction kit. Sequencing was performed using Big Dye Terminator 3.1 (Applied Biosystems) and reactions run on the Applied Biosystems 3130xl sequencer. All new sequence data has been deposited in GenBank (JN255800–JN255818).
Full genomic sequencing of HeV isolates using Next Generation sequencing (454)
Following isolation of HeV, the tissue culture supernatant was clarified at 10,000 rpm for 20 min before ultracentrifugation through a 15% sucrose cushion to semi-purify of the virus. The virus pellet was resuspended in 350 µL RLT buffer and extracted using the RNeasy kit (Qiagen) according to manufacturer's instructions.
RNA was denatured at 65°C for 5 min in the presence of 1 µL of the cDNA primer (20 µM) 5′ GTTTCCCAGTAGGTCTCNNNNNNNN 3′ then placed on ice. The RNA was reverse transcribed at 50°C for 1 hour using Superscript III First Strand Synthesis system (Invitrogen) and 4 µL of 5× First Strand buffer, 1 µL 0.1 M DTT, 1 µL RNase OUT and 1 µl Superscript III. The sample was denatured at 100°C for 2 min then cooled on ice. Double strand synthesis was performed at 37°C for 30 min using 1 µL Klenow polymerase (Promega) following the addition of 2.5 µL of DNA polymerase buffer and 1 µL of the cDNA primer (20 µM). The enzyme was inactivated and then random PCR was performed on 2 µL of cDNA using GoTaqHotStart (Promega) and 4 µL of MID primer (20 µM) (MID1 5′acgaGTGCGTGTTTCCCAGTAGGTCTC3′, MID2 5′acgcTCGACAGTTTCCCAGTAGGTCTC 3′, MID3 5′agacGCACTCGTTTCCCAGTAGGTCTC 3′, MID4 5′agcaCTGTAGGTTTCCCAGTAGGTCTC 3′) to create template for 454 sequencing by amplification as follows: 1 cycle at 95°C for 5 min, 40 cycles at 94°C for 1 min, 50°C for 1 min, 72°C for 2 min and a final extension at 72°C for 7 min.
PCR products (10 µL) were electrophoresed on a 1% agarose gel in 1× Tris Acetate EDTA buffer to check that the amplification was successful. The remaining reaction was purified using the QIAquick spin kit (Qiagen). The purified products were processed for sequencing on the 454 Genome Sequencer FLX system (Roche) using titanium chemistry according to manufacturer's instructions for Rapid Library Preparation and emPCR Lib-L SV method manuals (454 Life Sciences, Branford, CT, USA). Any gaps in the sequence alignment, or any required confirmation of the sequence, were performed using conventional sequencing.
Data from the 454 Genome Sequencer (Roche) was analysed using the CLC Genomic Workbench v4.5.1 (CLC inc, Aarhus, Denmark) and CloneManager Professional v9.11 (Scientific and Educational Software, NC, USA). Alignments for Sanger sequencing were performed using SeqMan Pro v9.0.4 (DNASTAR). Phylogenetic analyses were undertaken using the MEGA 5 software package using neighbour-joining bootstrap analysis .
Isolation of HeV from bat urine
Virus isolation was attempted from 30 samples positive by q-PCR, collected between Dec 2008 and March 2010 from multiple locations and species (Field et al 2011). Virus was isolated from 4 samples (Table 2). Although HeV has been isolated from foetal tissue and the reproductive tract of Pteropus poliocephalus and Pteropus alecto , the isolation of virus (on four occasions) in this study from pooled urine samples collected under-roost represents the first isolation of HeV from bat urine. Isolations from bat urine were equally successful in Vero cells and primary bat cell lines with no increased isolation in the primary bat cell lines. Interestingly, there was no correlation between a low Ct value (high quantity of RNA) in the TaqMan assay and the successful isolation of HeV. Similar findings have previously been observed when isolation attempts have been performed on human and horse samples [I. Smith, unpublished results]. This lack of isolation may be suggestive of non-viable virus being released during infection.
Sequencing at the sites of the TaqMan assays
Sequencing was undertaken on 11 samples. Initial sequencing of the HeV RNA centred around the locations of the HeV TaqMan assay primers and probes in the M gene and N gene ,  in order to identify variability that could lead to a false negative diagnostic PCR result. There were two changes present, at nucleotide 1561 for the majority of the HeV variants and at nucleotide 1673 in the Peachester variant from 2007. These change/s were likely responsible for the failure of the N gene TaqMan assay to detect the Peachester 2006 and 2007 variants in naturally infected horses. There was one change at nucleotide 5815 in the area of the genome targeted by the reverse primer used in the M gene TaqMan in the bat isolates from Yeppoon, Cedar Grove and Tolga Scrub and in the variant isolated from a horse in Bowen. However, this change did not prevent the M gene TaqMan detecting the virus on these occasions.
Whole genome sequence of four bat isolates
Next generation sequencing of the HeV isolates HeV/Australia/Bat/2009/Cedar Grove 11c, HeV/Australia/Bat/2009/Tolga Scrub 30g, HeV/Australia/Bat/2009/Yeppoon 4a and HeV/Australia/Bat/2009/Yeppoon 47a using the 454 Genome Sequencer (Roche), was undertaken to obtain sequence for the whole genome. The final trimmed data ranged from 2.3 MB to 13.3 MB of bases with between 73.3% (4877 bp missing) and 99.7% coverage (49 bp missing) of the HeV genome (Table 3). The quality of the material was proportional to the completeness of the genome.
Sequence from a total of 10 samples from this study (6 variants sequenced from PCR amplification, plus 4 isolates) was included in the phylogenetic analysis. A segment of the HeV genome from nucleotide 1500 to 2240 was selected for initial amplification and analysis for variant variation. This region encompassed the hypervariable carboxyl terminal of the nucleoprotein gene, spanning the intergenic region between the nucleoprotein and the phosphoprotein. There were 39 nucleotide positions in this region with changes when the 25 HeV variants fully or partly sequenced were compared to the HeV reference sequence GenBank NC_001906 (Hendra 1994).
Different variants of HeV were found to be present at the same time at the same location. For example, isolates HeV/Australia/Bat/2009/Yeppoon 47a and variant HeV/Australia/Bat/2009/Yeppoon 26-18 that were collected at the same location (Yeppoon) on the same date and were shown to be different (Figure 1, indicated by a star). Likewise, from Tolga Scrub, isolate HeV/Australia/Bat/2009/Tolga Scrub 30g and variant HeV/Australia/Bat/2009/Tolga Scrub 29-13 were collected on the same day but were different (Figure 1, indicated by a triangle) as was the isolate HeV/Australia/Bat/2009/Cedar Grove 11c and variant HeV/Australia/Bat/2009/Cedar Grove 23-9 from Cedar Grove (Figure 1, indicated by a circle). In addition, the same variants HeV/Australia/Bat/2009/Tolga Scrub 30g, HeV/Australia/Bat/2009/Yeppoon 4a and HeV/Australia/Bat/2009/Yeppoon 47a were found to be circulating in two different locations (Tolga Scrub and Yeppoon) which are 850 km apart (Figure 2).
Bat variants sequenced from PCR amplification are indicated in pink and horse and human variants in black. Yeppoon collection 15/8/09, Cedar Grove collection 5/8/09, Tolga Scrub collection 24/8/09).
Some geographical grouping was observed with the HeV/Australia/Bat/2009/Slacks Creek variant displaying greatest similarity with the outbreak variants HeV/Australia/Horse/2008/Redlands; and the HeV/Australia/Bat/2009/Yeppoon 26-18 variant showing similarity to HeV/Australia/Horse/2009/Cawarral. Comparison of the phylogenetic tree generated from the full length HeV sequences (Figure 3) revealed similar clustering to the 740 bp N-P region from nucleotide 1500 to 2240 (Figure 1). In both cases the newly isolated bat variants grouped together.
In order to assess other regions in the HeV genome for their suitability for phylogenetic analysis, a plot of the number of changes over the length of the HeV genome was conducted (Figure 4). Regions of greatest variability were centred around each of the intergenic regions, although an area of variability was observed in the P gene between nucleotide 3000 and 3600 (Figure 4). When the 11 full length sequences of HeV variants were compared with the reference sequence, there were 155 positions in the intergenic regions and 305 positions in the coding regions of the genome where there were changes. This equates to 2.5 times more changes per length of sequence occurring in the intergenic regions than in the coding region when compared with the reference variant.
Coding regions for the six major viral proteins are indicated beneath variability map.
Based on the analysis, the region encompassing the N-P (nucleotide 1561–2385) and P-M (nucleotide 4288–5065) intergenic regions within the Hendra genome could be used to differentiate the HeV variants as these produced phylogenetic trees with similar clustering patterns to the full length genome with good differentiation (Figure 5).
The current study has expanded our knowledge of Hendra virus variant diversity and provided an insight into the HeV variants circulating within the flying fox populations.
Diversity of the HeV variants circulating within the migrating populations of flying foxes was observed, with multiple HeV variants circulating at the one time at multiple locations (Cedar Grove, Yeppoon, Tolga Scrub). In addition, the same variant was circulating at multiple locations as evidenced by the isolation of virus from both Yeppoon and Tolga Scrub, which are over 860 km apart by direct distance.
Analysis of the hypervariable region of the genome allowed for variants of HeV to be differentiated from one another by nucleotide changes, despite the overall genome displaying genetic stability as previously observed . This genetic stability suggests that HeV is well adapted to its host, with coevolution resulting in minimal pressure to change over time. There were 2.5 times as many changes per length of sequence in the intergenic regions as there were in the coding regions when compared to the Hendra 1994 reference variant, suggesting that either changes in the intergenic regions are tolerated more than changes in coding regions, or that there is less selective pressure in the intergenic regions.
Similar clustering of isolates was observed regardless of the hypervariable region selected for analysis, although some regions gave better differentiation. Due to possibilities for variation in the genome, it is recommended that multiple TaqMan assays be used for the diagnosis of HeV. In addition, ongoing monitoring of HeV variability in bat populations is crucial for maintaining confidence in detection of variants.
Multiple variants circulating at the one time were observed previously in July 2008 when there were two concurrent outbreaks in horses over 930 km apart (direct distance) in the Redland suburb of Thornlands, and in Proserpine in Queensland. Concurrent outbreaks of HeV activity that spanned over 1400 kms was observed in August 2009, with the spillover of HeV at Cawarral (involving multiple fatal horse cases and one fatal human case) and the detections of HeV at Tolga Scrub, Yeppoon and Cedar Grove. Concurrent HeV activity was again detected in September 2009; in Bowen in a horse, and in Yeppoon and Cedar Grove in bats, a direct distance of over 600 km.
There were new introductions and a continual circulation of variants into a single flying fox population at Cedar Grove over the study period as the HeV variants (HeV/Australia/Bat/2009/Cedar Grove 11c, HeV/Australia/Bat/2009/Cedar Grove 23-9 and HeV/Australia/Bat/2010/Cedar Grove 48.8) are all different (Figure 1). This plausibly occurred with the migration of different species of flying fox into the roost, as that the typically predominantly P. alecto colony was periodically augmented by populations of P. poliocephalus and P. scapulatus during the study period (Field et al., 2011).
With such a mixture of variants circulating in flying fox populations throughout Queensland, it suggests that spillover events are not controlled by particular isolates, and that other factors that have led to the increase in outbreaks observed. These factors could include an improved awareness of HeV infection in horses, as well as an increase in the urbanisation of the flying fox populations leading to increased contact with horses and therefore humans . Other factors in the flying fox population such as pregnancy and environmental stressors have also been suggested to increase HeV emergence .
Spillovers of HeV from flying foxes into horses are most likely due to the increased incidence of horses coming into contact with excretions from flying foxes when compared to humans. In addition, horses may be more susceptible to HeV infection as their innate immune response genes are genetically most closely related to flying foxes . Intimate contact between horses and humans have been found to be required for infection, however, no direct transmission from bats to humans has been detected. The possibility of direct HeV infection from bats to humans cannot be ruled out. When spillovers occur from horses to humans the variation observed in HeV variants is minimal. There was 100% homology for the complete genome between isolates for a horse and the female human infected in the Redlands 2008 outbreak, whilst there was only one change observed in the intergenic region between the N and P gene in the fatal case human case from the same outbreak. There were only two changes detected between the variants infecting horse and human from the Cawarral 2009 outbreak.
This study has built on our understanding of the ecology and the frequency of HeV in flying fox colonies, although more research is needed to fully elucidate all mechanisms involved in the maintenance and transmission of HeV.
We thank Judy Northill and Doris Genge from QHFSS for technical assistance and Eric Hanssen from AAHL for design of some of the primers used in this study. We thank the Griffith University sequencing facility and the AAHL sequencing facility for running of sequencing reactions.
Conceived and designed the experiments: HEF IS. Performed the experiments: IS ACB GAS FAM JB GC GM MT MY CEdJ AZ CSS YHK HEF. Analyzed the data: IS. Contributed reagents/materials/analysis tools: L-FW. Wrote the paper: IS HEF L-FW GM ACB JB.
- 1. Eaton BT, Mackenzie JS, Wang L-F (2006) Henipaviruses. Chapter 45. In Fields Virology 5th edition. Knipe DM, Howley PM, editors. pp. 1587–1600. Published by Lippincott Williams and Wilkins.
- 2. Smith IL, Broos A, Smith GA (2010) Hendra virus. Chapter 28. In Molecular detection of human viral pathogens. Published by CRC Press.
- 3. Murray K, Eaton B, Hooper P, Wang L, Williamson M, et al. (1998) Flying foxes, horses and humans: a zoonosis caused by a new member of the Paramyxoviridae. In Emerging Infections 1: 43–58. Scheld WM, Armstrong D, Hughes JM, editors. Emerging infections 1. Published by American Society for Microbiology Press.
- 4. Halpin K, Young PL, Field HE, Mackenzie JS (2000) Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol 81: 1927–1932.
- 5. Young PL, Halpin K, Selleck PW, Field H, Gravel JL, et al. (1996) Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis 2: 239–240.
- 6. Hyatt AD, Selleck PW (1996) Ultrastructure of equine morbillivirus. Virus Res 43: 1–15.
- 7. Wang LF, Yu M, Hannsson E, Pritchard LI, Shiell B, et al. (2000) The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol 74: 9972–9979.
- 8. Murray K, Rogers R, Selvey L, Selleck P, Hyatt A, et al. (1995) A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis 1: 31–33.
- 9. Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, et al. (1995) Infection of humans and horses by a newly described morbillivirus. Med J Aust 162: 642–645.
- 10. Rogers RJ, Douglas IC, Baldock FC, Glanville RJ, Seppanen KT, et al. (1996) Investigation of a second focus of equine morbillivirus infection in coastal Queensland. Aust Vet J 74: 243–244.
- 11. Hooper PT, Gould AR, Russel GM, Kattenbelt JA, Mitchell G (1996) The retrospective diagnosis of a second outbreak of equine morbillivirus infection. Aust Vet J 74: 244–245.
- 12. Field HE, Barratt PC, Hughes RJ, Shield J, Sullivan ND (2000) A fatal case of Hendra virus infection in a horse in north Queensland: clinical and epidemiological features. Aust Vet J 7: 279–280.
- 13. Hanna JN, McBride WJ, Brookes DL, Shield J, Taylor CT, et al. (2006) Hendra virus infection in a veterinarian. Med J Aust 185: 562–564.
- 14. Murray G (2005) Miscellaneous: Hendra virus findings in Queensland, Australia. Disease Information 18: 66.
- 15. Arthur R (2006) Hendra virus Animal Health Surveillance 11(4): 8.
- 16. Promed 20070903.2897 (2007) Hendra virus, Human, Equine - Australia: (Queensland)(03) Correction.
- 17. Promed 20080717.2168 (2008) Hendra virus, Human, Equine - Australia (02): (Queensland, New South Wales).
- 18. Field H, Schaaf K, Kung N, Simon C, Waltisbuhl D, et al. (2010) Hendra virus outbreak with novel clinical features, Australia. Emerg Infect Dis 16: 338–340.
- 19. Playford EG, McCall B, Smith G, Slinko V, Allen G, et al. (2010) Hendra virus encephalitis associated with an equine outbreak; Clinical, laboratory and public health aspects. Emerging Inf Dis 16: 219–223.
- 20. Promed 20090811.2862 (2009) Hendra virus, Equine - Australia: (Queensland).
- 21. Promed 20090903.3098 (2009) Hendra virus, Human, Equine - Australia (04): (Queensland) Fatal.
- 22. Promed 20100520.1673 (2010) Hendra virus, Equine-Australia (Queensland).
- 23. Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, et al. (1998) Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats. Aust Vet J 76: 813–818.
- 24. Fogarty R, Halpin K, Hyatt AD, Saszak P, Mungall BA (2008) Henipavirus susceptibility to environmental variables. Virus Res 132: 140–144.
- 25. Field H, de Jong C, Melville D, Smith C, Smith I, et al. (2011) Hendra virus infection dynamics in Australian fruit bats. Submitted to PLos One.
- 26. Chua KB (2003) A novel approach for collecting samples from fruit bats for isolation of infectious agents. Microbes Infect 5: 487–490.
- 27. Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, et al. (2005) Bat Nipah virus, Thailand. Emerg Infect Dis.11: 1949–1951.
- 28. Crameri G, Todd S, Grimley S, McEachern JA, Marsh GA, et al. (2009) Establishment, immortalisation and characterisation of pteropid bat cell lines. PLoS One 4: e8266.
- 29. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular Biology and Evolution 24: 1596–1599.
- 30. Smith IL, Halpin K, Warrilow D, Smith GA (2001) Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus. J Virol Methods 98: 33–40.
- 31. OIE (2010) Hendra and Nipah virus diseases, In Manual of diagnostic tests and vaccines for terrestrial animals, 2010 Chapter 2.9.6.
- 32. Marsh GA, Todd S, Foord A, Hansson E, Davies K, et al. (2010) Genome sequence conservation of Hendra virus isolates during spillover to horses, Australia. Emerg Infect Dis 16: 1767–1769.
- 33. Plowright RK, Foley P, Field HE, Dobson AP, Foley JE, et al. (2011) Urban habituation, ecological connectivity and epidemic dampening: the emergence of Hendra virus from flying foxes (Pteropus spp.). Proc Biol Sci.
- 34. Plowright RK, Field HE, Smith C, Divljan A, Palmer C, et al. (2008) Reproduction and nutritional stress are risk factors for Hendra virus infection in little red flying foxes (Pteropus scapulatus). Proc Biol Sci 275: 861–869.
- 35. Cowled C, Baker M, Tachedjian M, Zhou P, Bulach D, et al. (2011) Molecular characterisation of Toll-like receptors in the black flying fox Pteropus alecto. Dev Comp Immunol 35: 7–18.